This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dow, G. S. Articles by Bhattacharjee, A. K. Search for Related Content PubMed PubMed Citation Articles by Dow, G. S. Articles by Bhattacharjee, A. K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2004, p. 2624-2632, Vol. 48, No. 7
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.7.2624-2632.2004

The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains

Divisions of Experimental Therapeutics,¹ Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910²

Received 16 September 2003/ Returned for modification 25 November 2003/ Accepted 3 March 2004

The clinical potential of mefloquine has been compromised by reports of adverse neurological effects. A series of 4-quinolinecarbinolamines were compared in terms of neurotoxicity and antimalarial activity in an attempt to identify replacement drugs. Neurotoxicity (MTT [thiazolyl blue reduction] assay) was assessed by exposure of cultured embryonic rat neurons to graded concentrations of the drugs for 20 min. The 50% inhibitory concentration (IC₅₀) of mefloquine was 25 µM, while those of the analogs were 19 to 200 µM. The relative (to mefloquine) therapeutic indices of the analogs were determined after using the tritiated hypoxanthine assay for assessment of the antimalarial activity of the analogs against mefloquine-sensitive (W2) and -resistant (D6 and TM91C235) Plasmodium falciparum strains. Five analogs, WR157801, WR073892, WR007930, WR007333, and WR226253, were less neurotoxic than mefloquine and exhibited higher relative therapeutic indices (RTIs) against TM91C235 (2.9 to 12.2). Conventional quinoline antimalarials were generally less neurotoxic (IC₅₀s of 400, 600, and 900 for amodiaquine, chloroquine, and quinine) or had higher RTIs (e.g., 30 for halofantrine against TM91C235). The neurotoxicity data for the 4-quinolinecarbinolamines were used to develop a three-dimensional (3D), function-based pharmacophore. The crucial molecular features correlated with neurotoxicity were a hydrogen bond acceptor (lipid) function, an aliphatic hydrophobic function, and a ring aromatic function specifically distributed in the 3D surface of the molecule. Mapping of the 3D structures of a series of structurally diverse quinolines to the pharmacophore allowed accurate qualitative predictions of neurotoxicity (or not) to be made. Extension of this in silico screening approach may aid in the identification of less-neurotoxic quinoline analogs.

This article has been cited by other articles:

• Dow, G. S., Chen, Y., Andrews, K. T., Caridha, D., Gerena, L., Gettayacamin, M., Johnson, J., Li, Q., Melendez, V., Obaldia, N. III, Tran, T. N., Kozikowski, A. P. (2008). Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors. Antimicrob. Agents Chemother. 52: 3467-3477 [Abstract] [Full Text]  
• Dow, G. S., Heady, T. N., Bhattacharjee, A. K., Caridha, D., Gerena, L., Gettayacamin, M., Lanteri, C. A., Obaldia, N. III, Roncal, N., Shearer, T., Smith, P. L., Tungtaeng, A., Wolf, L., Cabezas, M., Yourick, D., Smith, K. S. (2006). Utility of Alkylaminoquinolinyl Methanols as New Antimalarial Drugs. Antimicrob. Agents Chemother. 50: 4132-4143 [Abstract] [Full Text]  
• Xie, L. H., Li, Q., Lin, A. J., Smith, K., Zhang, J., Skillman, D. S. (2006). New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.. Antimicrob. Agents Chemother. 50: 1649-1655 [Abstract] [Full Text]